BRPI1010799A2 - lactoferrina e saúde neuronal e desenvolvimento no intestino infantil - Google Patents

lactoferrina e saúde neuronal e desenvolvimento no intestino infantil

Info

Publication number
BRPI1010799A2
BRPI1010799A2 BRPI1010799A BRPI1010799A BRPI1010799A2 BR PI1010799 A2 BRPI1010799 A2 BR PI1010799A2 BR PI1010799 A BRPI1010799 A BR PI1010799A BR PI1010799 A BRPI1010799 A BR PI1010799A BR PI1010799 A2 BRPI1010799 A2 BR PI1010799A2
Authority
BR
Brazil
Prior art keywords
lactoferrin
childhood
neuronal health
gut development
gut
Prior art date
Application number
BRPI1010799A
Other languages
English (en)
Inventor
Bing Wang
Jeroen Antonius Johannes Schmitt
Magali Faure
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1010799A2 publication Critical patent/BRPI1010799A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Pediatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1010799A 2009-05-12 2010-05-07 lactoferrina e saúde neuronal e desenvolvimento no intestino infantil BRPI1010799A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159968A EP2251031A1 (en) 2009-05-12 2009-05-12 Lactoferrin and neuronal health and development in the infant gut
PCT/EP2010/056234 WO2010130641A1 (en) 2009-05-12 2010-05-07 Lactoferrin and neuronal health and development in the infant gut

Publications (1)

Publication Number Publication Date
BRPI1010799A2 true BRPI1010799A2 (pt) 2016-04-05

Family

ID=41119325

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010799A BRPI1010799A2 (pt) 2009-05-12 2010-05-07 lactoferrina e saúde neuronal e desenvolvimento no intestino infantil

Country Status (11)

Country Link
US (1) US8445429B2 (pt)
EP (2) EP2251031A1 (pt)
JP (1) JP2012526745A (pt)
CN (1) CN102458447B (pt)
BR (1) BRPI1010799A2 (pt)
CA (1) CA2761437A1 (pt)
MX (1) MX2011012072A (pt)
RU (1) RU2552328C2 (pt)
TW (1) TWI407919B (pt)
WO (1) WO2010130641A1 (pt)
ZA (1) ZA201109090B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2251032A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and protection in adults
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
AU2012273206B2 (en) 2011-06-20 2015-09-24 H.J. Heinz Company Brands Llc Probiotic compositions and methods
PL2594282T3 (pl) * 2011-11-21 2015-01-30 Nestec Sa Laktoferyna i istota biała
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
ES2672194T3 (es) * 2012-12-18 2018-06-13 Mjn U.S. Holdings Llc Composiciones nutricionales a base de leche que contienen lactoferrina y sus usos
US9301966B2 (en) * 2013-01-11 2016-04-05 Mead Johnson Nutrition Company Nutritional compositions containing magnesium threonate and uses thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
MX2016001225A (es) * 2013-09-02 2016-05-24 Nestec Sa Lactoferrina y memoria y velocidad de aprendizaje en niños.
US20150157048A1 (en) * 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US10517918B2 (en) * 2013-12-13 2019-12-31 Societe Des Produits Nestle S.A. Use of a modified sweet whey and a modified sweet whey containing infant formula for promoting the postnatal development of the infant central nervous system and related cognitive functions
MX374376B (es) 2013-12-13 2025-03-06 Soc Des Produits Nestle S A Star Uso de un suero de leche dulce que contiene una fórmula infantil para promover el desarrollo neuronal posnatal del tracto gastrointestinal del infante, y el establecimiento de las funciones intestinales que lo controlan.
CN104187740A (zh) * 2014-09-15 2014-12-10 天添爱(青岛)生物科技有限公司 一种半固体的婴幼儿及儿童辅食营养素补充食品
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2020096672A1 (en) * 2018-11-09 2020-05-14 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells
WO2020159356A1 (en) 2019-02-01 2020-08-06 N.V. Nutricia Native whey protein for improving intestinal maturation
CN115989874B (zh) * 2022-09-07 2023-10-20 合生元（广州）健康产品有限公司 一种改善肠屏障健康的蛋白组合物及其应用
WO2025114592A1 (en) * 2023-11-30 2025-06-05 Société des Produits Nestlé S.A. Nutritional composition for promoting social development
CN118020946A (zh) * 2024-03-06 2024-05-14 美赞臣婴幼儿营养品技术(广州)有限公司 保护肠道屏障和/或预防中枢神经系统疾病的营养组合物及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
JPH0779684B2 (ja) * 1989-02-27 1995-08-30 森永乳業株式会社 ビフィズス菌増殖促進組成物
JP2660908B2 (ja) * 1995-02-24 1997-10-08 森永乳業株式会社 ビフィズス菌増殖促進性及び生残性が良好なヨーグルト
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
PL199861B1 (pl) 1999-04-29 2008-11-28 Nestle Sa Preparat dla niemowląt i sposób wytwarzania preparatu
DK1480524T3 (da) * 2002-03-07 2013-07-15 Upfront Chromatography As Fremgangsmåde til isolering af lactoferrin
JP4452569B2 (ja) * 2004-06-29 2010-04-21 有限会社フードデザイン健康研究所 桃の花及びラクトフェリンを主成分とする食品
US20060068022A1 (en) * 2004-09-29 2006-03-30 Playford Raymond J Bioactive agent compositions for repair of cell injuries
WO2007145520A1 (en) * 2006-06-14 2007-12-21 N.V. Nutricia Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
WO2007145220A1 (ja) 2006-06-14 2007-12-21 Panasonic Corporation 書き換え可能な回路を備える装置、更新システム、更新方法、更新プログラム、及び集積回路
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
ITRM20060434A1 (it) * 2006-08-07 2008-02-08 Pietro Raimondi Prodotto da somministrare all organismo umano per isuoi effetti protettivi e curativi a base di latte di bufala autorricchito di lattoferrina oppure di lattoferrina tal quale ottenuto attraverso processi separativi di membrana
EP2251030A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
EP2251032A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and protection in adults
EP2251029A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and gut neuronal health in adults and/or elderly

Also Published As

Publication number Publication date
EP2251031A1 (en) 2010-11-17
CA2761437A1 (en) 2010-11-18
US8445429B2 (en) 2013-05-21
US20120184483A1 (en) 2012-07-19
ZA201109090B (en) 2013-07-31
EP2429571A1 (en) 2012-03-21
JP2012526745A (ja) 2012-11-01
EP2429571B1 (en) 2017-10-18
MX2011012072A (es) 2012-02-23
CN102458447B (zh) 2015-01-07
RU2552328C2 (ru) 2015-06-10
CN102458447A (zh) 2012-05-16
WO2010130641A1 (en) 2010-11-18
TWI407919B (zh) 2013-09-11
TW201100024A (en) 2011-01-01
RU2011150191A (ru) 2013-06-20

Similar Documents

Publication Publication Date Title
BRPI1010799A2 (pt) lactoferrina e saúde neuronal e desenvolvimento no intestino infantil
BRPI1012211A2 (pt) lactoferrina e desenvolvimento e saúde cerebral em crianças
BRPI1012147A2 (pt) lactoferrina e saúde e proteção do cérebro em adultos
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0822064A2 (pt) Dispositivos de imageamento fotoacústico e métodos de imageamento
SMT201500186B (it) Autoanticorpi umani anti-alfa-sinucleina
BRPI1008835A2 (pt) sensor de analito e aparelho para inserção do sensor
BR112013013699A2 (pt) fixação de barra de exercícios e método
DK2517557T4 (da) Dyremodeller og terapeutiske molekyler
BRPI0917089A2 (pt) métodos e sistemas planos de ação personalizados
BRPI0914558A2 (pt) dispositivo e métodos de manuseio tunular
BR112012004586A2 (pt) aprelho de iluminação e aparelho de exibição
FI20085334A0 (fi) Harjoitusmenetelmä ja -järjestelmä
EP2476717A4 (en) POLYAMIDE AND POLYAMIDE COMPOSITION
PT3151354T (pt) Alojamento e dispositivo de selagem
BRPI0910116A2 (pt) desvio transparente e mecanismos associados
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
BRPI0814876A2 (pt) Análogos de pirona fosforilados e métodos
EP2261637A4 (en) METHOD FOR CONTROLLING RESISTIVITY AND DEVICE THEREFOR
IT1393306B1 (it) Apparecchio di misura e controllo
CR10956S (es) Arithmetic and control unit
BR112012010242A2 (pt) derivados de heteroarilpiperidina e heteroarilpiperazina
EP2400565A4 (en) LED AND LED PACKAGE
BRPI1007909A2 (pt) método e dispositivo médico
BRPI0907561A2 (pt) Materiais e métodos para aperfeiçoamento da saúde de camarões

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/40 (2006.01), A23L 33/19 (2016.0

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.